Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Godzinski

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|July 13, 2015
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trialKathy Pritchard-Jones, Christophe Bergeron, Beatriz de Camargo, et al.
Pediatric Blood & Cancer|April 29, 2021
The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in childrenDaniel Orbach, Andrea Ferrari, Dominik T Schneider, et al.
Pediatric Blood & Cancer|March 24, 2021
Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescentsDominik T Schneider, Daniel Orbach, Tal Ben-Ami, et al.
Pediatric Blood & Cancer|April 21, 2021
Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsTeresa Stachowicz-Stencel, Anna Synakiewicz, Marianna Cornet, et al.
Pediatric Blood & Cancer|June 26, 2021
Facing the challenges of very rare tumors of pediatric age: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievementsAndrea Ferrari, Dominik T Schneider, Gianni Bisogno, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2019
Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare TumorsAndrea Ferrari, Ines B Brecht, Gemma Gatta, et al.
Pediatric Blood & Cancer|June 26, 2021
Cutaneous melanoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsAndrea Ferrari, Ricardo Lopez Almaraz, Yves Reguerre, et al.
Pediatric Blood & Cancer|June 26, 2021
Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsCalogero Virgone, Jelena Roganovic, Peter Vorwerk, et al.
Pediatric Blood & Cancer|June 26, 2021
Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendationsEwa Bien, Jelena Roganovic, Malgorzata A Krawczyk, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2025
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)Tim Flaadt, Lauriane Lemelle, Michael Abele, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|July 13, 2015
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trialKathy Pritchard-Jones, Christophe Bergeron, Beatriz de Camargo, et al.
Pediatric Blood & Cancer|April 29, 2021
The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in childrenDaniel Orbach, Andrea Ferrari, Dominik T Schneider, et al.
Pediatric Blood & Cancer|March 24, 2021
Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescentsDominik T Schneider, Daniel Orbach, Tal Ben-Ami, et al.
Pediatric Blood & Cancer|April 21, 2021
Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsTeresa Stachowicz-Stencel, Anna Synakiewicz, Marianna Cornet, et al.
Pediatric Blood & Cancer|June 26, 2021
Facing the challenges of very rare tumors of pediatric age: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievementsAndrea Ferrari, Dominik T Schneider, Gianni Bisogno, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2019
Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare TumorsAndrea Ferrari, Ines B Brecht, Gemma Gatta, et al.
Pediatric Blood & Cancer|June 26, 2021
Cutaneous melanoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsAndrea Ferrari, Ricardo Lopez Almaraz, Yves Reguerre, et al.
Pediatric Blood & Cancer|June 26, 2021
Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsCalogero Virgone, Jelena Roganovic, Peter Vorwerk, et al.
Pediatric Blood & Cancer|June 26, 2021
Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendationsEwa Bien, Jelena Roganovic, Malgorzata A Krawczyk, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2025
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)Tim Flaadt, Lauriane Lemelle, Michael Abele, et al.
Pageof 6